Our Firm is representing numerous women in transvaginal mesh lawsuits filed against Ethicon. We are pleased that the federal proceeding is moving forward.
New York, New York (PRWEB) June 19, 2014
Transvaginal mesh lawsuits (http://www.transvaginalmeshlawsuithelp.com/) filed against Ethicon, Inc. continue to move forward in the U.S. District Court, Southern District of West Virginia, Bernstein Liebhard LLP reports. According to court documents, an Order issued by the Court on June 17th requires the preservation of mesh explanted from plaintiffs who undergo surgery due to vaginal mesh complications. Among other things, the Order directs the parties to meet and confer regarding the protocols governing the transfer, preservation, and division of mesh explants after they are released by the health care facility where the surgery was performed. (In re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation - MDL No. 2327)
“Our Firm is representing numerous women in transvaginal mesh lawsuits filed against Ethicon. We are pleased that the federal proceeding is moving forward," says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to investigate transvaginal mesh lawsuits on behalf of women who suffered serious complications, allegedly due to products marketed by Ethicon and other manufacturers.
Transvaginal Mesh Lawsuits
More than 18,000 transvaginal mesh lawsuits have been filed in the federal Ethicon litigation, all of which allege the company’s pelvic mesh products were defectively designed and manufactured, and caused recipients to suffer serious and debilitating vaginal mesh complications. Bernstein Liebhard LLP partner, Jeffrey S. Grand, is serving on the Plaintiffs’ Steering Committee for this proceeding.
According to court documents, Ethicon is just one of several defendants involved in pelvic mesh litigations in the Southern District of West Virginia, where more than 55,000 vaginal mesh lawsuits have been filed. Mr. Grand is also a member of the Plaintiffs’ Steering Committees in proceedings involving: American Medical Systems, Inc. (MDL No. 2325); Boston Scientific Corp., (MDL No. 2326); and C.R. Bard, Inc., (MDL No. 2187).
Mr. Grand is also serving as Co-Liaison Counsel in two multicounty litigations underway in New Jersey Superior Court for transvaginal mesh lawsuits involving products marketed by C.R. Bard and Ethicon. He was also a member of the Plaintiff’s trial team on the first Ethicon trial in that proceeding, which ended in March with a jury awarding $11 million in compensatory and punitive damages to a woman who suffered vaginal mesh complications related to the Ethicon Gynecare Prolift device. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)
Women who received transvaginal mesh in surgeries to treat pelvic organ prolapse or stress urinary incontinence may be entitled to compensation if they experienced mesh erosion, chronic pain, or other serious vaginal mesh complications. To learn more about filing a transvaginal mesh lawsuit, please visit Bernstein Liebhard LLP’s website, or the Firm's Facebook page: https://www.facebook.com/meshlawsuit. To obtain a free, confidential and no-obligation case review, please call 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York State’s contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm’s fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff’s recovery.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP